Loading clinical trials...
Loading clinical trials...
A Phase 1 Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Bioavailability of IV and SC AL101
Conditions
Interventions
AL101
Placebo
Locations
2
United States
Study site
Miami, Florida, United States
Study site
Orlando, Florida, United States
Start Date
December 14, 2019
Primary Completion Date
June 9, 2022
Completion Date
June 9, 2022
Last Updated
August 10, 2022
NCT07470866
NCT00104325
NCT07221448
NCT07388667
NCT06637865
NCT07118891
Lead Sponsor
Alector Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions